CN110734995A - 一种检测利什曼原虫的引物对、探针及检测方法和试剂盒 - Google Patents
一种检测利什曼原虫的引物对、探针及检测方法和试剂盒 Download PDFInfo
- Publication number
- CN110734995A CN110734995A CN201911301367.6A CN201911301367A CN110734995A CN 110734995 A CN110734995 A CN 110734995A CN 201911301367 A CN201911301367 A CN 201911301367A CN 110734995 A CN110734995 A CN 110734995A
- Authority
- CN
- China
- Prior art keywords
- primer
- leishmania
- probe
- seq
- probes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000523 sample Substances 0.000 title claims abstract description 89
- 241000222722 Leishmania <genus> Species 0.000 title claims abstract description 60
- 238000001514 detection method Methods 0.000 title claims abstract description 28
- 210000001185 bone marrow Anatomy 0.000 claims abstract description 19
- 210000003491 skin Anatomy 0.000 claims abstract description 7
- 238000006243 chemical reaction Methods 0.000 claims description 45
- 230000003321 amplification Effects 0.000 claims description 38
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 38
- 238000003753 real-time PCR Methods 0.000 claims description 33
- 239000003153 chemical reaction reagent Substances 0.000 claims description 10
- 239000012154 double-distilled water Substances 0.000 claims description 9
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 8
- 238000012408 PCR amplification Methods 0.000 claims description 8
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 4
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 239000007853 buffer solution Substances 0.000 claims description 4
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 4
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 claims description 4
- 230000035945 sensitivity Effects 0.000 abstract description 13
- 210000005259 peripheral blood Anatomy 0.000 abstract description 11
- 239000011886 peripheral blood Substances 0.000 abstract description 11
- 239000012634 fragment Substances 0.000 abstract description 6
- 239000003814 drug Substances 0.000 abstract description 2
- 230000000694 effects Effects 0.000 abstract description 2
- 238000011841 epidemiological investigation Methods 0.000 abstract description 2
- 238000012544 monitoring process Methods 0.000 abstract description 2
- 230000002349 favourable effect Effects 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 description 39
- 238000002156 mixing Methods 0.000 description 20
- 239000013612 plasmid Substances 0.000 description 19
- 239000007788 liquid Substances 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 8
- 208000004554 Leishmaniasis Diseases 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- 239000000975 dye Substances 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 238000011529 RT qPCR Methods 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 230000010355 oscillation Effects 0.000 description 4
- 239000013600 plasmid vector Substances 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 239000013062 quality control Sample Substances 0.000 description 4
- 238000011002 quantification Methods 0.000 description 4
- 238000001179 sorption measurement Methods 0.000 description 4
- 229960000723 ampicillin Drugs 0.000 description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 241000156948 Aphantopus hyperantus Species 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000589562 Brucella Species 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 108010067770 Endopeptidase K Proteins 0.000 description 2
- 241000222727 Leishmania donovani Species 0.000 description 2
- 206010024229 Leprosy Diseases 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 241000224016 Plasmodium Species 0.000 description 2
- 241001052560 Thallis Species 0.000 description 2
- 241000223996 Toxoplasma Species 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000012149 elution buffer Substances 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000005087 mononuclear cell Anatomy 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 206010039766 scrub typhus Diseases 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 206010040882 skin lesion Diseases 0.000 description 2
- 231100000444 skin lesion Toxicity 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000255129 Phlebotominae Species 0.000 description 1
- 241000227142 Rhododendron tomentosum Species 0.000 description 1
- 206010047505 Visceral leishmaniasis Diseases 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000001046 green dye Substances 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 239000003761 preservation solution Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/6893—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for protozoa
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911301367.6A CN110734995B (zh) | 2019-12-17 | 2019-12-17 | 一种检测利什曼原虫的引物对、探针及检测方法和试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911301367.6A CN110734995B (zh) | 2019-12-17 | 2019-12-17 | 一种检测利什曼原虫的引物对、探针及检测方法和试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110734995A true CN110734995A (zh) | 2020-01-31 |
CN110734995B CN110734995B (zh) | 2020-04-17 |
Family
ID=69274594
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911301367.6A Active CN110734995B (zh) | 2019-12-17 | 2019-12-17 | 一种检测利什曼原虫的引物对、探针及检测方法和试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110734995B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111549160A (zh) * | 2020-05-08 | 2020-08-18 | 刘东立 | 一种用于检测利什曼原虫的引物组、试剂盒及其应用 |
CN111808973A (zh) * | 2020-08-06 | 2020-10-23 | 中国疾病预防控制中心寄生虫病预防控制所(国家热带病研究中心) | 一种用于鉴定三平正并殖吸虫囊蚴的试剂盒及使用方法 |
CN111876512A (zh) * | 2020-07-29 | 2020-11-03 | 深圳市疾病预防控制中心 | 等温扩增检测两种利什曼原虫的试剂、试剂盒及其应用 |
CN113897448A (zh) * | 2021-11-12 | 2022-01-07 | 四川国际旅行卫生保健中心(成都海关口岸门诊部) | 一种对利士曼原虫进行多重串联式pcr基因碟片检测的引物及方法和试剂盒 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101613752A (zh) * | 2009-05-27 | 2009-12-30 | 中国人民解放军军事医学科学院军事兽医研究所 | 快速检测杜氏利什曼原虫的荧光定量pcr试剂盒 |
CN102590508A (zh) * | 2012-03-12 | 2012-07-18 | 中国疾病预防控制中心寄生虫病预防控制所 | 检测亲内脏利什曼原虫感染和诊断黑热病的免疫层析试条 |
EP2631300A1 (en) * | 2012-02-23 | 2013-08-28 | Biosure R & T Cell Co. | Detection of leishmania |
US20170260595A1 (en) * | 2011-10-24 | 2017-09-14 | The United States Of America As Represented By The Department Of Veteran Affairs | Serial quantitative pcr assay for detection, species-discrimination and quanitification of leishmania spp. in human samples |
CN108588252A (zh) * | 2018-03-29 | 2018-09-28 | 杭州泰熙生物技术有限公司 | 一种寄生虫检测试剂盒及其检测方法 |
-
2019
- 2019-12-17 CN CN201911301367.6A patent/CN110734995B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101613752A (zh) * | 2009-05-27 | 2009-12-30 | 中国人民解放军军事医学科学院军事兽医研究所 | 快速检测杜氏利什曼原虫的荧光定量pcr试剂盒 |
US20170260595A1 (en) * | 2011-10-24 | 2017-09-14 | The United States Of America As Represented By The Department Of Veteran Affairs | Serial quantitative pcr assay for detection, species-discrimination and quanitification of leishmania spp. in human samples |
EP2631300A1 (en) * | 2012-02-23 | 2013-08-28 | Biosure R & T Cell Co. | Detection of leishmania |
CN102590508A (zh) * | 2012-03-12 | 2012-07-18 | 中国疾病预防控制中心寄生虫病预防控制所 | 检测亲内脏利什曼原虫感染和诊断黑热病的免疫层析试条 |
CN108588252A (zh) * | 2018-03-29 | 2018-09-28 | 杭州泰熙生物技术有限公司 | 一种寄生虫检测试剂盒及其检测方法 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111549160A (zh) * | 2020-05-08 | 2020-08-18 | 刘东立 | 一种用于检测利什曼原虫的引物组、试剂盒及其应用 |
CN111876512A (zh) * | 2020-07-29 | 2020-11-03 | 深圳市疾病预防控制中心 | 等温扩增检测两种利什曼原虫的试剂、试剂盒及其应用 |
CN111808973A (zh) * | 2020-08-06 | 2020-10-23 | 中国疾病预防控制中心寄生虫病预防控制所(国家热带病研究中心) | 一种用于鉴定三平正并殖吸虫囊蚴的试剂盒及使用方法 |
CN113897448A (zh) * | 2021-11-12 | 2022-01-07 | 四川国际旅行卫生保健中心(成都海关口岸门诊部) | 一种对利士曼原虫进行多重串联式pcr基因碟片检测的引物及方法和试剂盒 |
Also Published As
Publication number | Publication date |
---|---|
CN110734995B (zh) | 2020-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110734995B (zh) | 一种检测利什曼原虫的引物对、探针及检测方法和试剂盒 | |
CN113583885B (zh) | 酵母菌株及其在石油烃降解中的应用 | |
KR20180081527A (ko) | 클로스트리듐 박테리아의 형질전환을 위한 유전자 도구 | |
CN108026556A (zh) | 在具有经改造的输入/输出的微生物宿主中人乳寡糖的产生 | |
CN113454230B (zh) | 一种通过体细胞重编程制备诱导多能干细胞的方法 | |
CA2464199A1 (en) | A composition and method to alter lean body mass and bone properties in a subject | |
CN106916828A (zh) | 一种调控杨树叶片发育的生长调节因子基因及其应用 | |
CN110951736B (zh) | 一种核定位信号f4nls及其在提高碱基编辑效率与拓展可编辑碱基范围中的应用 | |
CN111705062A (zh) | 二苯乙烯类雌激素核酸适体及其应用 | |
CN113699186A (zh) | 基因表达盒、慢病毒载体及其在治疗β地中海贫血症的应用 | |
US6696278B1 (en) | Method for transfer of DNA segments | |
CN110184290B (zh) | 一种用于生产大分子量透明质酸的遗传重组质粒及工程菌与应用 | |
RU2731513C2 (ru) | Генотерапевтический ДНК-вектор на основе генотерапевтического ДНК-вектора VTvaf17, несущий целевой ген, выбранный из группы генов NOS2, NOS3, VIP, KCNMA1, CGRP, для повышения уровня экспрессии этих целевых генов, способ его получения и применения, штамм Escherichia coli SCS110-AF/VTvaf17-NOS2, или Escherichia coli SCS110-AF/VTvaf17-NOS3, или Escherichia coli SCS110-AF/VTvaf17-VIP, или Escherichia coli SCS110-AF/VTvaf17-KCNMA1, или Escherichia coli SCS110-AF/VTvaf17-CGRP, несущий генотерапевтический ДНК-вектор, способ его получения, способ производства в промышленных масштабах генотерапевтического ДНК-вектора | |
CN114807140B (zh) | 一种肌源性细胞血糖响应型表达sia的启动子、重组载体及其构建方法和应用 | |
CN114591417B (zh) | 人源单链胰岛素类似物及其应用 | |
CN112538493B (zh) | 全基因组沉默子筛选系统及其应用 | |
CN108707575B (zh) | 一种获得武夷菌素高产菌株的方法 | |
Bach et al. | The isolation and characterization of a novel microsome fraction from washed and detergent-treated nuclei of HeLa cells by the use of solutions containing deoxyribonucleic acid | |
RU2732479C2 (ru) | Генотерапевтический ДНК-вектор на основе генотерапевтического ДНК-вектора VTvaf17, несущий целевой ген, выбранный из группы генов BDNF, VEGFA, BFGF, NGF, GDNF, NT3, CNTF, IGF1, для повышения уровня экспрессии этих целевых генов, способ его получения и применения, штамм Escherichia coli SCS110-AF/VTvaf17-BDNF, или Escherichia coli SCS110-AF/VTvaf17-VEGFA, или Escherichia coli SCS110-AF/VTvaf17-BFGF, или Escherichia coli SCS110-AF/VTvaf17-NGF, или Escherichia coli SCS110-AF/VTvaf17-GDNF, или Escherichia coli SCS110-AF/VTvaf17-NT3, или Escherichia coli SCS110-AF/VTvaf17-CNTF, или Escherichia coli SCS110-AF/VTvaf17-IGF1, несущий генотерапевтический ДНК-вектор, способ его получения, способ производства в промышленных масштабах генотерапевтического ДНК-вектора | |
WO1998033529A1 (en) | Treatment for urinary incontinence using gene therapy techniques | |
RU2720519C1 (ru) | Генотерапевтический ДНК-вектор на основе генотерапевтического ДНК-вектора VTvaf17, несущий целевой ген, выбранный из группы генов IFNB1, IFNA14, IFNA2, IL12A, IL12B для повышения уровня экспрессии этих целевых генов, способ его получения и применения, штамм Escherichia coli SCS110-AF/VTvaf17-IFNB1, или Escherichia coli SCS110-AF/VTvaf17-IFNA14, или Escherichia coli SCS110-AF/VTvaf17-IFNA2, или Escherichia coli SCS110-AF/VTvaf17-IL12A, или Escherichia coli SCS110-AF/VTvaf17-IL12B, несущий генотерапевтический ДНК-вектор, способ его получения, способ производства в промышленных масштабах генотерапевтического ДНК-вектора | |
CN113801889B (zh) | 细胞筛选模型及其构建方法和应用、酵母菌及其制备方法和应用 | |
CN112899209A (zh) | 一种锌离子诱导重组蛋白表达体系、其诱导方法和应用 | |
CN114174519A (zh) | 用于生产包含重组内肽酶的酶组合物的方法 | |
CN109852628B (zh) | 一种基于诱导性启动子鉴定微生物基因功能的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220209 Address after: 225300 third floor, G19, Yaocheng Avenue, Taizhou City, Jiangsu Province Patentee after: JIANGSU BIOPERFECTUS TECHNOLOGIES CO.,LTD. Address before: 100050 Yongan Road, Xicheng District, Xicheng District, Beijing Patentee before: BEIJING FRIENDSHIP HOSPITAL, CAPITAL MEDICAL University |
|
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: No. 837, Yaocheng Avenue, Taizhou, Jiangsu 225300 Patentee after: JIANGSU BIOPERFECTUS TECHNOLOGIES CO.,LTD. Address before: 225300 third floor, G19, Yaocheng Avenue, Taizhou City, Jiangsu Province Patentee before: JIANGSU BIOPERFECTUS TECHNOLOGIES CO.,LTD. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220810 Address after: No. 837, Yaocheng Avenue, Taizhou, Jiangsu 225300 Patentee after: JIANGSU BIOPERFECTUS TECHNOLOGIES CO.,LTD. Patentee after: Shanghai Shuoying Biotechnology Co., Ltd. Address before: No. 837, Yaocheng Avenue, Taizhou, Jiangsu 225300 Patentee before: JIANGSU BIOPERFECTUS TECHNOLOGIES CO.,LTD. |